# Ernexa Therapeutics Inc.: Form 8-K, filed May 11, 2021

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2021-05-11
- Accepted by EDGAR: May 11, 2021, 17:25 ET
- Period: 2021-05-06
- Accession: 0001140361-21-016863
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036121016863/brhc10024430_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036121016863/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036121016863/brhc10024430_8k.htm

Filed May 11, 2021.
Source: SEC EDGAR, the filing index for accession 0001140361-21-016863. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.